Region | Disease group | Male | Female | ||||||||
35+ (RR) | 35–64 | 65+ | 35+ (RR) | 35–64 | 65+ | ||||||
PE | SAF | PE | SAF | PE | SAF | PE | SAF | ||||
Rural | Cancer | 1.68 | 28.85 | 16.38 | 25.72 | 14.87 | 1.64 | 1.31 | 0.83 | 1.84 | 1.16 |
Cardiovascular | 1.33 | 28.85 | 8.76 | 25.72 | 7.88 | 3.72 | 1.31 | 3.43 | 1.84 | 4.77 | |
Respiratory | 1.86 | 28.85 | 19.94 | 25.72 | 18.17 | 3.76 | 1.31 | 3.49 | 1.84 | 4.85 | |
Urban | Cancer | 1.68 | 27.81 | 15.88 | 28.23 | 16.09 | 1.64 | 0.92 | 0.58 | 1.06 | 0.67 |
Cardiovascular | 1.33 | 27.81 | 8.46 | 28.23 | 8.58 | 3.72 | 0.92 | 2.43 | 1.06 | 2.8 | |
Respiratory | 1.86 | 27.81 | 19.36 | 28.23 | 19.59 | 3.76 | 0.92 | 3.47 | 1.06 | 2.84 |
Authors’ calculations are based on the survey data and mortality ratio approach to estimate relative risks (RR).
PE, smoking prevalence for ever smokers; SAF, smoking-attributable fraction.